Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Prenatal stem cell transplants may open door to organ transplants, treating genetic diseases

07.11.2002


In a finding that could open the door to future treatments for many genetic diseases such as sickle cell anemia and muscular dystrophy, researchers have produced high levels of transplanted, healthy stem cells in mice, while sharply reducing a hazardous side effect of cell and organ transplants called graft-versus-host disease.


By combining prenatal transplants of blood-forming stem cells with manipulations of blood cells after birth, researchers at The Children’s Hospital of Philadelphia achieved immune tolerance in mice, allowing donor cells to multiply without toxic side effects. The studies appear in related articles in the August and September issues of Blood.

The finding could greatly broaden the use of cell and organ transplants for genetic diseases detected before birth, such as leukemia, sickle cell disease, muscular dystrophy, and some kidney and liver disorders.

"Recent developments in genetic knowledge and technology are converging to make it likely that within a decade, nearly all human genetic diseases will be diagnosed before birth," says Alan W. Flake, M.D., director of the Children’s Institute for Surgical Science at The Children’s Hospital of Philadelphia, and senior author of both articles. "Our research may greatly expand our ability to use prenatal interventions to help the body safely tolerate treatments for genetic diseases."



Dr. Flake’s team used a prenatal procedure called in utero hematopoietic stem cell transplantation (IUHSCT). Hematopoietic stem cells develop into red blood cells, white blood cells and a variety of immune cells. The stem cells used in these studies were taken from the bone marrow of adult mice, not from human embryos.

As a disease treatment, prenatal stem cell transplants have faced a major barrier in that they have been unable to achieve high levels of engraftment – the number of donor stem cells usually does not grow large enough to overcome the effect of diseased cells. An exception to this limitation is diseases in which donor cells have a normal advantage over the transplant recipient’s cells. For instance, Dr. Flake was able to cure a child of a rare immune disease, X-linked severe combined immunodeficiency disorder (X-SCID), by using a prenatal stem cell transplant in 1996 that rebuilt his immune system.

Dr. Flake’s current studies potentially extend prenatal stem cell transplants to a broader range of diseases, by manipulating conditions to create a competitive advantage for donor cells over host cells. The IUHSCT procedure first makes the recipient’s immune system tolerant of low levels of donor cells, and then a second, nontoxic procedure after birth provides a competitive advantage for the transplanted donor cells, allowing them to multiply.

"Performing the stem cell transplant prenatally relies on features of the fetal immune system that are more receptive to transplantation," said Dr. Flake. "For instance, the immaturity of the fetal immune system makes it less able to mount an immune response against the transplanted cells." Paradoxically, the technique also relies on a strength of the fetal immune system: its healthy thymus, a gland that declines in function after puberty. The fetal thymus produces T-regulatory cells, which help to reduce graft-versus-host disease. In that disease, a life-threatening complication of cell and organ transplants, donor cells attack the patient’s tissues.

The second, postnatal step of the treatment compromises host blood cells and allows the donor cells to engraft themselves in the recipient’s bone marrow and bloodstream. Because the prenatal transplant has made the host animal tolerant of donor cells, the postnatal procedure can be less toxic than conventional treatments that use harsh chemotherapy drugs or high-dose radiation to wipe out the host’s existing immune system.

In one study, Dr. Flake used donor lymphocyte infusion (DLI) as the postnatal treatment. Currently used against some leukemias, DLI supplies lymphocytes, donated immune cells that weaken or kill host blood cells. In the other study, the postnatal treatment was low-dose full-body irradiation followed by bone marrow transplantation. Graft-versus-host disease was minimal in the DLI study, killing only one mouse out of 56, and did not occur at all in the other study.

The procedures achieved complete or near-complete chimerism – meaning that all, or nearly all, of the animal’s blood cells were derived from the donor stem cells, even though the donor animals were not matched with the recipients. "This was the first time that complete chimerism was achieved across mismatched donors and recipients without using toxic therapy," said Dr. Flake. "If this strategy can be made to work in people, there are broad implications for treating human disease."

Potential applications to disease treatment

"This approach could potentially target any diseases that are now treatable with bone marrow transplants," adds Dr. Flake. "These include blood cell diseases such as leukemias, thalassemia and sickle cell disease, as well as many inherited immunodeficiency disorders."

Beyond that, he added, the technique might also treat muscular dystrophy, an incurable genetic disease that impairs muscle development. In previous research, Dr. Flake’s team showed that stem cells transplanted in utero can develop into healthy muscle cells in mice with muscular dystrophy.

Organ transplant recipients might also benefit from the technique’s ability to make a patient’s immune system tolerant of the donated organ. "If prenatal screening predicts that a fetus would have kidney or liver failure, the prenatal stem cell transplant could prepare the immune system for a future transplant," says Dr. Flake. "A tolerized immune system would better accept an organ transplant from an unmatched donor."

Although prenatal screening is not yet widespread for many genetic diseases, he adds, currently emerging technologies will make it feasible to diagnose nearly all genetic diseases early in gestation within the next 10 years. "The combination of data from the Human Genome Project, improvements in molecular diagnoses, gene chip technology, and the ability to do molecular diagnoses of fetal cells or fetal DNA within the mother’s blood, all support early gestational diagnosis of genetic disease," says Dr. Flake.

Dr. Flake cautions that the clinical applications may be years away, but based on these results, he will further investigate stem cell transplantation in mice and then in larger animals, with the goal of translating the approach to treatments for people.

John Ascenzi | EurekAlert!
Further information:
http://www.chop.edu

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Antarctic landscape insights keep ice loss forecasts on the radar

20.11.2017 | Earth Sciences

Filling the gap: High-latitude volcanic eruptions also have global impact

20.11.2017 | Earth Sciences

Water world

20.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>